Stay informed, stay ahead.
Researchers have found early signs that an mRNA vaccine — like those used for COVID-19 — could help the immune system fight certain cancers. In a study involving more than 1,000 patients with advanced lung or skin cancer, people who received an mRNA vaccine within 100 days of starting immunotherapy lived significantly longer. This suggests…
Trodelvy, developed by Gilead Sciences, has delivered promising results in a late-stage trial for advanced triple-negative breast cancer (TNBC). Researchers found that the drug lowered the risk of disease progression by 38% compared to standard chemotherapy. The study enrolled 558 patients with TNBC whose tumours did not express PD-L1. Participants receiving Trodelvy reached a median…
